Parkinson's disease is a neurodegenerative disorder characterized by both motor and non-motor symptoms. The involvement of respiratory muscles can lead to impairments in respiratory function in these patients. In this study is to evaluate the thickness of abdominal accessory respiratory muscles using ultrasonography in patients with Parkinson's disease. Additionally, the relationship between disease severity and expiratory respiratory muscle strength will be examined. The study will include Parkinson's patients at different stages of the disease, with respiratory muscle thickness measured via ultrasonography. The collected data will then be compared with disease severity and expiratory muscle strength.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Maximal Expiratory Pressure (MEP) Measurement
Timeframe: to be measured only once at the start day 1
Maximal Inspiratory Pressure (MIP) Measurement
Timeframe: to be measured only once at the start day 1
Ultrasonographic Assessment of Abdominal Accessory Respiratory Muscles
Timeframe: to be measured only once at the start day 1